The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC-Reference-Cited by-同舟云学术

The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC

Published:2024-08-06 Issue:1 Volume:16 Page:
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Jiang Huiyong¹^ORCID,Yu Ying²^ORCID,Hu Xiaoxiang¹^ORCID,Du Bingbing³^ORCID,Shao Yini¹^ORCID,Wang Feiyu¹^ORCID,Chen Lifeng¹^ORCID,Yan Ren¹^ORCID,Li Lanjuan¹^ORCID,Lv Longxian¹^ORCID

Affiliation:

1. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

2. School of Public Health, Hangzhou Medical College, Hangzhou, China

3. Microecological Laboratory, Jinan Microecological Biomedicine Shandong Laboratory, Jinan, China

Funder

Research and Development

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Medical and Health Plan of Zhejiang Province

Natural Science Foundation of Zhejiang Province

Shandong Provincial Laboratory Project

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2024.2383353

Reference42 articles.

1. Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?

2. Primary biliary cholangitis

3. Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases†

4. Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis

5. Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets